Dr. Stuart Schnitt Explores Ibex Breast AI Advancement at USCAP 2024

Back

USCAP (United States and Canadian Academy of Pathology) is the largest North American organization of pathologists. At USCAP 2024, Dr. Stuart Schnitt (Dana-Farber Cancer Institute) explored the transformative role of AI in breast cancer diagnostics. Highlighting current challenges of artificial intelligence and cancer, he showcased Ibex’s Breast algorithm’s ability to enhance diagnostic accuracy across a spectrum of breast lesions. He also introduces a study which validates Ibex across multiple institutions, confirming the position of AI in pathology.

Back

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News

The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics